VSEE Company Profile and Key Details

VSee Health, Inc. earnings surprise history is a mixed track record. The quarter that ended May 15, 2026, missed forecasts by -54.55%. The prior quarter beat by 287.5%. Over the last six quarters, Apple has recorded several small beats. These include 33.33% in May 28, 2025.

VSee Health, Inc. has 16.42 million shares outstanding. The public float is 6.54 million shares, elevated short interest at 1.24% of float. This equals 90.11 thousand shares. The short ratio is 0.49 days. Institutional investors hold 11.89% of the float. Insiders own 10.41%.

VSEE has shown mixed momentum, gaining 5.1% over the past week and -12.3% over the past quarter, though year-to-date performance is up 11.78%. Short-term trend indicators are bullishly aligned (SMA20 8.13%, SMA50 -3.89%, SMA200 -52.05%). The stock’s 14-day RSI is 52.87 (neutral), while the ATR of 0.03 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -85.04% below its high and over 22.17% above its low. Average 10-day trading volume of 4.16 million shares is significantly above the 3-month average of 2.48 million, indicating heightened recent market interest.

VSee Health, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$0.25. This means the shares are trading below this model’s fair value.

VSee Health, Inc. (NASDAQ:VSEE) closed at $0.11 USD, gaining $0.01 (7.22%) from the previous close of $0.10. The stock is currently mid-range between its 52-week high and low $0.09 and $2.52. With a market capitalization of about $1.72 million, VSee Health, Inc. is classified as a micro-cap and shows lower-than-market volatility (beta ~0.49). Key stats such as the average daily volume over the past year has been around 2.48 million shares, trading with heavier-than-usual volume. Headquartered in Newton, MA, VSee Health, Inc. operates in the Healthcare sector and the Medical - Healthcare Information Services industry. Led by CEO Milton Chen, the company employs approximately 209 people and listed since December 31, 2021. VSee Health, Inc. specializes in delivering virtual healthcare solutions.

VSee Health, Inc. trades at a P/E ratio of -0.2, slightly below the S&P 500 average, with a price-to-sales ratio of 0.12 and a price-to-book ratio of 0.8 suggesting the stock is closer to book value. The P/FCF stands at -0.31, also above market averages.

Our AI price prediction model suggests that VSee Health, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -28.86%, with price expected at $0.07 by July 28, 2026, within a range of $0.05 to $0.09 3-Month Outlook: Projected fall of -89.84%, reaching $0.01 by October 12, 2026, with a range of $0.00 to $0.04. 1-Year Outlook: Projected loss of -100.0%, with price at $0.00 by July 14, 2027, within a range of $0.00 to $0.10.

VSee Health, Inc. (NASDAQ:VSEE) shares are up 11.78% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows VSee Health, Inc. trading at a premium to the broader market with a P/E of -0.2. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $5.00, suggesting 4981.3% upside. Our AI forecast model points to short-term weakness (-28.86% over two weeks), a medium-term fall (-89.84% over three months), and a longer-term loss (-100.0% over one year), with expected trading ranges indicating moderate volatility.